JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease-Reference-Cited by-同舟云学术

JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease

Published:2020-04-24 Issue:5 Volume:84 Page:831-865
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Nakamura Masato¹,Kimura Kazuo²,Kimura Takeshi³,Ishihara Masaharu⁴,Otsuka Fumiyuki⁵,Kozuma Ken⁶,Kosuge Masami²,Shinke Toshiro⁷,Nakagawa Yoshihisa⁸,Natsuaki Masahiro⁹,Yasuda Satoshi⁵,Akasaka Takashi¹⁰,Kohsaka Shun¹¹,Haze Kazuo¹²,Hirayama Atsushi¹³

Affiliation:

1. Division of Cardiovascular Medicine, Toho University Ohashi Medical Center

2. Division of Cardiology, Yokohama City University Medical Center

3. Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine

4. Department of Cardiovascular and Renal Medicine, Hyogo College of Medicine

5. Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center

6. Division of Cardiology, Department of Internal Medicine, Teikyo University School of Medicine

7. Division of Cardiology, Department of Medicine, Showa University School of Medicine

8. Division of Cardiovascular Medicine, Department of Internal Medicine, Shiga University of Medical Science

9. Department of Cardiovascular Medicine, Saga University

10. Department of Cardiovascular Medicine, Wakayama Medical University

11. Department of Cardiology, Keio University School of Medicine

12. Department of Cardiology, Kashiwara Municipal Hospital

13. Cardiovascular Division, Osaka Police Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/84/5/84_CJ-19-1109/_pdf

Reference203 articles.

1. 1. 　Kimura K, Kimura T, Ishihara M, et al. Japanese Circulation Society Joint Working Group. JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome. Circ J 2019; 83: 1085–1196. PMID: 30930428

2. 2. 　Nakamura M, et al. JCS 2018 guideline on revascularization of stable coronary artery disease. 2019.

3. 3. 　Kang J, Park KW, Palmerini T, et al. Racial differences in ischaemia/bleeding risk trade-off during anti-platelet therapy: Individual patient level landmark meta-analysis from seven RCTs. Thromb Haemost 2019; 119: 149–162. PMID: 30597509

4. 4. 　Levine GN, Jeong YH, Goto S, et al. Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Nat Rev Cardiol 2014; 11: 597–606. PMID: 25154978

5. 5. 　Urban P, Mehran R, Colleran R, et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: A consensus document from the Academic Research Consortium for High Bleeding Risk. Circulation 2019; 140: 240–261. PMID: 31116032

Cited by 227 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical implications of combination proton pump inhibitor and triple therapies in patients with atrial fibrillation following percutaneous intervention: a guide for clinicians;Expert Review of Cardiovascular Therapy;2024-09-12

2. Prior coronary stent does not exclude major pulmonary resection regardless of antiplatelet therapy;Surgery Today;2024-09-09

3. Balancing Act　― Prasugrel’s Efficacy and Safety in Japanese Patients Undergoing Percutaneous Coronary Intervention ―;Circulation Journal;2024-09-03

4. Comparative incidence and risk factors for gastrointestinal bleeding following percutaneous coronary intervention for coronary artery disease: Insights from the Keio Cardiovascular Registry in Japan;Thrombosis Research;2024-09

5. Antithrombotic management in atrial fibrillation patients following percutaneous coronary intervention: A clinical review;Journal of Arrhythmia;2024-08-08